These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 4683145)
41. Is psychiatry in a crisis because of the complications of the psychopharmaceuticals? Ayd FJ Dis Nerv Syst; 1968 Mar; 29(3):Suppl:23-5. PubMed ID: 5672559 [No Abstract] [Full Text] [Related]
42. [Current neuroleptics in the treatment of depressions]. Volmat R; Allers G Therapeutique; 1970 Dec; 46(10):1017-20. PubMed ID: 5511927 [No Abstract] [Full Text] [Related]
43. [Psychotropic drugs (effects and indications)]. Calanca A Rev Med Suisse Romande; 1974 Jul; 94(7):575-86. PubMed ID: 4842890 [No Abstract] [Full Text] [Related]
44. Psychotropic drugs and the elderly patient. Dellefield K; Miller J Nurs Clin North Am; 1982 Jun; 17(2):303-18. PubMed ID: 6919940 [No Abstract] [Full Text] [Related]
45. [Influence of lithium carbonate on the course of hyperthymic psychoses]. Branzei P; Balan G Acta Psychiatr Belg; 1974 May; 74(3):241-53. PubMed ID: 4455022 [No Abstract] [Full Text] [Related]
46. Improving psychiatric drug therapy. A matter of dosage and choice. Cole JO; Stotsky BA Geriatrics; 1974 Jun; 29(6):74-8. PubMed ID: 4364716 [No Abstract] [Full Text] [Related]
47. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years). Goldman D Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486 [No Abstract] [Full Text] [Related]
48. [Drug treatment of psychological disorders in adolescents]. Beverina M Sem Hop; 1983 Sep; 59(33):2297-302. PubMed ID: 6137875 [TBL] [Abstract][Full Text] [Related]
49. [Our clinical experience with sulpiride in psychiatry]. Ropert R; Lévy L; Ropert M; Coudière G; Weil D Sem Hop; 1970 Jun; 46(29):Suppl:109-16. PubMed ID: 4316821 [No Abstract] [Full Text] [Related]
50. [Oxazepam or WY 3498, a new muscle-relaxing tranquilizer in ambulatory treatment]. Bobon J; Collard J; Breulet M Acta Neurol Psychiatr Belg; 1965 May; 65(5):327-34. PubMed ID: 4953877 [No Abstract] [Full Text] [Related]
51. Tranquillisers and depression. Johnson FN Lancet; 1972 Apr; 1(7757):966-7. PubMed ID: 4112135 [No Abstract] [Full Text] [Related]
52. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia]. Scala A Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254 [No Abstract] [Full Text] [Related]
53. The impact of modern pharmacotherapy on the prognosis of psychiatric patients. Lehmann HE Trans Assoc Life Insur Med Dir Am; 1970; 53():31-47. PubMed ID: 5465245 [No Abstract] [Full Text] [Related]
54. Rapid and gentle pharmacotherapy of depression. Ostow M N Y State J Med; 1974 Jan; 74(1):74-7. PubMed ID: 4521706 [No Abstract] [Full Text] [Related]
55. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study). McLaughlin BE Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995 [No Abstract] [Full Text] [Related]
56. factors influencing response to major tranquilizer medications. Kimbell I; Overall JE; Faibish GM; Pokorny AD Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910 [No Abstract] [Full Text] [Related]
57. [Problems of psychopharmacotherapy]. Pohlmeier H Med Klin; 1966 Aug; 61(34):1313-8. PubMed ID: 5995192 [No Abstract] [Full Text] [Related]
58. Physical training. II. An activating type of treatment within psychiatry. Dencker SJ Scand J Rehabil Med; 1971; 3(1):57-60. PubMed ID: 4405583 [No Abstract] [Full Text] [Related]